OSSTEC

- 08/04/2025
- Unknown
- $3,196,236
Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them.
OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision is to keep patients active, pain-free and enjoying added years of improved quality of life.
- Industry Medical Equipment Manufacturing
- Website https://osstec.uk/
- LinkedIn https://www.linkedin.com/company/osstec/
Related People
Maxwell MunfordFounder

Translating innovation and technology from the lab to the operating room to improve patient care.
Founded OSSTEC to develop bone healing orthopaedic implants which use additive manufacturing to keep patients healthy and active. OSSTEC is a medical devices start-up based at Imperial College London combining world leading engineers, surgeons and technology for patient benefit. Currently seeking investment.
An ambitious PhD researcher in additive manufacture for orthopaedics and first class mechanical engineering graduate (results in top 12%) with experience in medical devices, engineering consultancy and manufacturing. Highly motivated by both deep research and translation in the medtech space.